Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Long-Term Investments (2016 - 2017)

Tenax Therapeutics' Long-Term Investments history spans 3 years, with the latest figure at $2.3 million for Q3 2017.

  • For Q3 2017, Long-Term Investments fell 86.83% year-over-year to $2.3 million; the TTM value through Sep 2017 reached $2.3 million, down 86.83%, while the annual FY2016 figure was $8.6 million, N/A changed from the prior year.
  • Long-Term Investments for Q3 2017 was $2.3 million at Tenax Therapeutics, down from $3.3 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $19.6 million in Q2 2016 and bottomed at $2.3 million in Q3 2017.
  • The 3-year median for Long-Term Investments is $8.6 million (2016), against an average of $10.7 million.
  • The largest annual shift saw Long-Term Investments tumbled 52.35% in 2016 before it crashed 86.83% in 2017.
  • A 3-year view of Long-Term Investments shows it stood at $18.0 million in 2015, then crashed by 52.35% to $8.6 million in 2016, then plummeted by 72.93% to $2.3 million in 2017.
  • Per Business Quant, the three most recent readings for TENX's Long-Term Investments are $2.3 million (Q3 2017), $3.3 million (Q2 2017), and $5.2 million (Q1 2017).